Intrauterine growth restriction programs an accelerated age-related increase in cardiovascular risk in male offspring

Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F312-9. doi: 10.1152/ajprenal.00123.2016. Epub 2016 May 4.

Abstract

Placental insufficiency programs an increase in blood pressure associated with a twofold increase in serum testosterone in male growth-restricted offspring at 4 mo of age. Population studies indicate that the inverse relationship between birth weight and blood pressure is amplified with age. Thus, we tested the hypothesis that intrauterine growth restriction programs an age-related increase in blood pressure in male offspring. Growth-restricted offspring retained a significantly higher blood pressure at 12 but not at 18 mo of age compared with age-matched controls. Blood pressure was significantly increased in control offspring at 18 mo of age relative to control counterparts at 12 mo; however, blood pressure was not increased in growth-restricted at 18 mo relative to growth-restricted counterparts at 12 mo. Serum testosterone levels were not elevated in growth-restricted offspring relative to control at 12 mo of age. Thus, male growth-restricted offspring no longer exhibited a positive association between blood pressure and testosterone at 12 mo of age. Unlike hypertension in male growth-restricted offspring at 4 mo of age, inhibition of the renin-angiotensin system with enalapril (250 mg/l for 2 wk) did not abolish the difference in blood pressure in growth-restricted offspring relative to control counterparts at 12 mo of age. Therefore, these data suggest that intrauterine growth restriction programs an accelerated age-related increase in blood pressure in growth-restricted offspring. Furthermore, this study suggests that the etiology of increased blood pressure in male growth-restricted offspring at 12 mo of age differs from that at 4 mo of age.

Keywords: accelerated aging; blood pressure; cardiovascular risk; low birth weight; renin-angiotensin system.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Arterial Pressure / drug effects
  • Birth Weight
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology*
  • Enalapril / therapeutic use
  • Female
  • Fetal Growth Retardation / pathology*
  • Hypertension / drug therapy
  • Hypertension / etiology
  • Male
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Renin-Angiotensin System / drug effects
  • Risk Factors
  • Testosterone / blood

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Testosterone
  • Enalapril